P

Prelude Therapeutics (PRLD)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Prelude Therapeutics (PRLD)

Prelude Therapeutics Inc. is a clinical-stage precision oncology company. The Company is focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers. Its drug discovery engine is designed to... Read more

  • 6.67
  • 6.80
  • 6.34
  • 15.57
  • 0.1%
  • --
  • 57.23k
  • 66.04k
  • 326M
  • 3.87
  • -52.3%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.